Christine M Hay MD
Associate Professor, Medicine, University of Rochester School of Medicine & Dentistry
Join to View Full Profile
601 Elmwood AveBox MedRochester, NY 14642
Phone+1 585-275-5871
Fax+1 585-273-1055
Dr. Hay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 1995 - 1998- Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1992 - 1995
Washington University in St. Louis School of MedicineClass of 1992
Certifications & Licensure
NY State Medical License 1999 - 2027
American Board of Internal Medicine Infectious Disease
Clinical Trials
- Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults Start of enrollment: 2006 Apr 01
- Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy Adults Start of enrollment: 2007 Apr 01
- Evaluating the Safety and Immune Response of a Prime-Boost HIV Vaccine Regimen in Healthy, HIV-Uninfected, Vaccinia-Naive Adults Start of enrollment: 2012 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsContinuous-flow left ventricular assist device systems infections: current outcomes and management strategies.Nana Aburjania, Christine M. Hay, Muhammad R Sohail
Annals of Cardiothoracic Surgery. 2021-03-01 - 8 citationsPasteurella Endocarditis: A Case Report and Statistical Analysis of the Literature.Randall S. Porter, Christine M. Hay
Case Reports in Infectious Diseases. 2020-07-20 - 40 citationsSafety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV ...Marnie Elizaga, Shuying S. Li, Nidhi Kochar, Gregory J. Wilson, Mary Allen
Plos One. 2018-09-20
Press Mentions
Should You Wait to Attend Med School?July 23rd, 2024
Grant Support
- Study Of Gd-Alum/Mpl HSV-2 Vaccine In Prevention Of Genital Herpes In WomenNational Center For Research Resources2005
- ACTG A5143National Center For Research Resources2004
- Immune Control Of HIV1 Disease ProgressionNational Institute Of Allergy And Infectious Diseases1999–2000
- Immune Control Of HIV1 Disease ProgressionNational Institute Of Allergy And Infectious Diseases1998
- HIV CTL In Progressive And Non-Progressive InfectionNational Institute Of Allergy And Infectious Diseases1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
